Abstract: Scroll compressors are provided with vapor injection or by-pass ports that will allow greater flow of refrigerant through the port than was the case in the prior art. The prior art has typically utilized a single injection port having a diameter equal to or slightly larger than the thickness of the scroll wrap. In this way, the scroll wrap is able to prevent or restrict cross-flow leakage from the port from passing between the two compression chambers. However, this single port has also limited the amount of refrigerant that can be returned. In one embodiment, the present invention utilizes a plurality of ports generally spaced along the length of the wrap such that cross-flow can still be prevented while providing a greater cross-sectional flow area into or out of the compression chambers. In another embodiment, the several ports may be replaced by a single elongated port.

Abstract: A method utilizing basketball rebounders, network connections, various sensors, video cameras, and output monitors to allow basketball shooters to engage in shooting competitions with one another without being in the same physical location.

Abstract: A compressor diagnostic system incorporates a control which receives a plurality of data streams about various operational features of the compressor. As an example, both temperature and pressure of the suction and discharge refrigerant are taken and sent to the control. Moreover, information with regard to the power being supplied to the motor is taken and stored. All of this information is utilized at a control which compares the information to expected values and determines a fault based upon the evaluation. Moreover, in another feature of this invention, much of this data is stored, and maintained at the compressor. In the event of a compressor failure, this stored information will provide a maintenance worker with a good indication of why the compressor failed.

Abstract: The invention provides an amphiphilic compound suitable for oil-in-water systems. The amphiphilic compound contains: (a) a lipophilic component that is hydrocarbon group containing about 20 or more carbon atoms; (b) a hydrophilic component selected from (i) a monomer or an oligomer of an oxyalkylene group containing 2 or more carbon atoms; (ii) a monomer or an oligomer of an oxyalkylene group containing 3 or more carbon atoms; (iii) an oligiomer containing: (1) an oxyalkylene group containing 3 or more carbon atoms; (2) an oxyalkylene group containing 2 or more carbon atoms, provided component (2) is different from component (1); (iv) a hydrocarbyl substituted hydroxyamino group; (v) a polyhydric alcohol group; and (vi) a polyamino group; and (c) a linker covalently bonding the hydrophilic component and the lipophilic component, wherein the hydrophilic component is present in an amount sufficient to at least partially disperse the amphiphilic compound in water.

Abstract: The system operates with a signal transmission/reception apparatus such as a receive antenna, or a coaxial system or the like, while the antenna is receiving information signals and it operates by injecting a low power pseudo-noise digital signal into the antenna and detecting reflected energy, the magnitude of which depends on the condition of the antenna. The reflected signal is processed and compared with the original test signal to produce a digital number representing the condition of the antenna. The digital number is compared with a table of numbers in a processor to determine the condition of the antenna.

Abstract: Kedarcidin is a protein antitumor antibiotic produced by Streptoalloteichus sp. nov. strain L585-6, ATCC 53650. The antibiotic comprises a non-protein chromophore and a single chain polypeptide having 114 amino acid residues.

Abstract: A novel complex designated herein as rigolettone complex is produced by fermentation of Streptomyces aburaviensis strain C-38,242 (ATCC 39290). The complex and its purified bioactive components, jildamycin and mantuamycin, exhibit antitumor activity in mouse tumor systems.

Abstract: A new cyclic depsipeptide antitumor antibiotic designated herein as sandramycin is produced by fermentation of a new microorganism, Nocardioides sp. strain C49,009, ATCC 39419. Sandramycin possesses antibacterial activity and inhibits the growth of tumors in experimental animals.

Abstract: Novel antitumor antibiotics designated herein as albacarcins M and V are produced by fermentation of Streptomyces albaduncas strain C-38291 (ATCC 39151). The new antibiotics possess antibacterial activity and also inhibit the growth of mammalian tumors such as P388 leukemia in mice.

Abstract: A new cyclic depsipeptide antitumor antibiotic designated herein as sandramycin is produced by fermentation of a new microorganism, Nocardioides sp. strain C49,009, ATCC 39419. Sandramycin possesses antibacterial activity and inhibits the growth of tumors in experimental animals.

Abstract: A novel antitumor agent designated herein as rebeccamycin is produced by fermentation of Nocardia aerocolonigenes (ATCC 39243). Rebeccamycin and its 5'-N-methyl and 5',2",3",6"-tetraacetate derivatives exhibit activity against experimental animal tumor systems.

Abstract: A novel antitumor agent designated herein as rebeccamycin is produced by fermentation of Nocardia aerocolonigenes (ATCC 39243). Rebeccamycin and its 5'-N-methyl and 5',2",3",6"-tetraacetate derivatives exhibit activity against experimental animal tumor systems.

Abstract: Novel antitumor antibiotics designated herein as albacarcins M and V are produced by fermentation of Streptomyces albaduncas strain C-38291 (ATCC 39151). The new antibiotics possess antibacterial activity and also inhibit the growth of mammalian tumors such as P388 leukemia in mice.

Abstract: A polycyclic antitumor antibiotic designated herein as anandimycin is produced by fermentation of Streptomyces anandii subsp. araffinosus strain C-22,437 (ATCC 31431). Anandimycin possesses antibacterial activity and inhibits the growth of tumors in experimental animals.

Abstract: A known antibiotic substance designated herein as rachelmycin is produced by fermentation of Streptomyces sp. strain C-329, variant 70 (ATCC 31128) or Streptomyces anandii subsp. arraffinosus strain C-22, 437 (ATCC 31431). Rachelmycin exhibits both antibiotic and antitumor properties.

Abstract: A novel anthracycline antibiotic complex designated herein as figaroic acid complex is produced by fermentation of Streptosporangium sp. strain C-31,751, A.T.C.C. 31129. Figaroic acid complex inhibits the growth of various microorganisms, e.g., Staphylococcus aureus, exhibits phage inducing properties and inhibits the growth of various tumors in rodents, e.g., Sarcoma 180, L-1210 lymphatic leukemia, B-16 melanoma, Walker 256 carcinosarcoma and P-388 lymphatic leukemia.

Abstract: A novel anthracycline antibiotic complex designated herein as figaroic acid complex is produced by fermentation of Streptosporangium sp. strain C-31,751, A.T.C.C. 31129. Figaroic acid complex inhibits the growth of various microorganisms, e.g., Staphylococcus aureus, exhibits phage inducing properties and inhibits the growth of various tumors in rodents, e.g., Sarcoma 180, L-1210 lymphatic leukemia, B-16 melanoma, Walker 256 carcinosarcoma and P-388 lymphatic leukemia.

Abstract: A novel anthracycline antibiotic complex designated herein as bohemic acid complex is produced by fermentation of Actinosporangium sp. A.T.C.C. 31127. The complex and two bioactive components designated marcellomycin and musettamycin exhibit antibiotic activity and inhibit the growth of various tumor systems in rodents.

Abstract: A novel anthracycline antibiotic complex designated herein as bohemic acid complex is produced by fermentation of Actinosporangium sp. A.T.C.C. 31127. The complex and two bioactive components designated marcellomycin and musettamycin exhibit antibiotic activity and inhibit the growth of various tumor systems in rodents.